LifeVantage (NASDAQ:LFVN) Earns Strong-Buy Rating from Analysts at StockNews.com

Posted by on Jun 26th, 2023

Equities research analysts at StockNews.com assumed coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a research report issued to clients and investors on Monday. The brokerage set a “strong-buy” rating on the stock.

LifeVantage Price Performance

LFVN stock opened at $4.50 on Monday. The stock has a market capitalization of $57.60 million, a price-to-earnings ratio of -75.00 and a beta of 1.05. The business’s fifty day moving average price is $4.26 and its two-hundred day moving average price is $3.91. LifeVantage has a fifty-two week low of $3.04 and a fifty-two week high of $5.74.

LifeVantage (NASDAQ:LFVN – Get Rating) last posted its quarterly earnings results on Thursday, May 4th. The company reported $0.08 EPS for the quarter. The business had revenue of $53.74 million during the quarter. LifeVantage had a positive return on equity of 3.32% and a negative net margin of 0.40%. Research analysts expect that LifeVantage will post 0.23 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of LFVN. Tower Research Capital LLC TRC grew its position in LifeVantage by 117.5% in the third quarter. Tower Research Capital LLC TRC now owns 11,362 shares of the company’s stock valued at $42,000 after acquiring an additional 6,138 shares during the last quarter. Susquehanna International Group LLP bought a new stake in shares of LifeVantage during the fourth quarter worth about $93,000. American Century Companies Inc. grew its holdings in shares of LifeVantage by 30.3% during the first quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock worth $219,000 after purchasing an additional 10,706 shares during the last quarter. State Street Corp grew its holdings in shares of LifeVantage by 7.6% during the first quarter. State Street Corp now owns 46,191 shares of the company’s stock worth $220,000 after purchasing an additional 3,281 shares during the last quarter. Finally, EP Wealth Advisors LLC bought a new stake in shares of LifeVantage during the first quarter worth about $234,000. Institutional investors own 27.92% of the company’s stock.

About LifeVantage

(Get Rating)

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.

Further Reading

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.